- Champions Oncology (NASDAQ:CSBR -6%) FQ2 results: Revenues: $3M (+57.9%); R&D Expense: $0.9M (-25.0%); SG&A: $2.5M (-3.8%); Net Loss: (2.5M) (+19.4%); Loss Per Share: ($0.29) (+47.3%); Non-GAAP Loss Per Share: ($0.24) (+52.0%); Quick Assets: $4.2M (-55.3%).
- No guidance given.
Champions Oncology reports FQ2 results
Recommended For You
More Trending News
About CSBR Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CSBR | - | - |
Champions Oncology, Inc. |